𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies

✍ Scribed by Christian F. Singer; Wolfgang J. Köstler; Gernot Hudelist

Book ID
113486672
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
946 KB
Volume
1786
Category
Article
ISSN
0304-419X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2/neu and EGFR tyrosine kinase activ
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man